Cardlytics (CDLX) Capital Expenditures (2017 - 2026)

Cardlytics' Capital Expenditures history runs 10 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Capital Expenditures rose 1117.11% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 209.46% YoY) and the FY2025 annual result came in at $480000.0, down 69.27% from the prior year.
• Capital Expenditures was $2.3 million for Q1 2026 at Cardlytics, up from $25000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $12.5 million in Q3 2024 and bottomed at -$11.9 million in Q4 2024.
• A 5-year average of $1.1 million and a median of $227500.0 in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2023 — Capital Expenditures plunged 2690.55% — and 2026, when it jumped 1117.11%.
• Cardlytics' Capital Expenditures stood at $11.0 million in 2022, then tumbled by 93.96% to $667000.0 in 2023, then plunged by 1878.26% to -$11.9 million in 2024, then jumped by 100.21% to $25000.0 in 2025, then surged by 9004.0% to $2.3 million in 2026.
• Business Quant data shows CDLX's Capital Expenditures at $2.3 million in Q1 2026, $25000.0 in Q4 2025, and $14000.0 in Q3 2025.